RxDoctor Payments Data

Hamta Zare

Nurse Practitioner · Stanford, CANPI 1164559555

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $371,434 of the $428,054 with a category attached, or 86.8%. 4 manufacturers reported payments, led by AbbVie at 51.4% of the total. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$428,054in general payments, 2019–2025

Across 888 payments — averaging $482.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$220K
  • Galderma Laboratories, L.p.$183K
  • Revance Therapeutics, Inc.$25K
  • Merz North America, Inc.$55

What the payments were for

  • Consulting fees$4,3971%
  • Speaking & faculty fees$371,43487%
  • Travel & lodging$30,7637%
  • Food & beverage$21,4175%
  • Education$420%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)429$220,091
Galderma Laboratories, L.p.416$182,542
Revance Therapeutics, Inc.41$25,366
Merz North America, Inc.2$55

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$428,054 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California →

Other nurse practitioner in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →